Pediatric Inflammatory Bowel Diseases: Clinical Trials

3 trials for Pediatric Inflammatory Bowel Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Not yet recruiting 1

Follow Pediatric Inflammatory Bowel Diseases: new trials by email Literature Review of Pediatric Inflammatory Bowel Diseases trials Research Report on Pediatric Inflammatory Bowel Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis
Oral Vancomycin - Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC)
Phase 2Not yet recruitingTampere University Hospital1402026-10-012026-09-10
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
Environmental microplastic exposure - Crohn Disease, Pediatric Inflammatory Bowel Diseases
RecruitingMedical University of Gdansk402025-06-152025-09-30
Exercise Training in Youth With Inflammatory Bowel Disease
Exercise training program - Pediatric Inflammatory Bowel Diseases, Pediatric Crohns Disease
Not applicableCompletedMcMaster University112013-05-012022-10-24

Narrower conditions

Colitis, Ulcerative (2)  ·  Cholangitis, Sclerosing (1)  ·  Colitis (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)  ·  Pediatric ulcerative colitis (1)

Broader conditions

Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Cholangitis (1)  ·  Colitis (1)  ·  Inflammatory Bowel Diseases (1)

Interventions

Vancomycin (1)

Sponsors

McMaster University (1)  ·  Medical University of Gdansk (1)  ·  Tampere University Hospital (1)

Countries

Canada (1)  ·  Finland (1)  ·  Poland (1)

Top investigators

Brian Timmons, PhD (1)

NIH funding

2025 (1)